title: The effect of high dose melatonin on cardiac ischemia- reperfusion Injury.
abstract: OBJECTIVE
  Melatonin, the most potent scavenger of toxic free radicals, has been found to be effective in protecting against pathological states due to the release of reactive oxygen species. This study was performed to establish the effect of high dose melatonin on protection against ischemia- reperfusion (I/R) injury in rat hearts.
  
  
  METHODS
  Forty male Sprague-Dawley rats were used in this study. They were separated into four groups of ten rats each. A left coronary artery occlusion was induced in the rats by ligating the artery for 20 minutes and then releasing the ligation (reperfusion) afterwards. The control group was Group A. Group B was subjected to myocardial ischemia-reperfusion without any treatment, while Group C underwent myocardial ischemia-reperfusion with a melatonin treatment before the ischemia. Group D was subjected to myocardial ischemia-reperfusion with a melatonin treatment before the reperfusion. After 20 minutes of reperfusion, blood samples were obtained from each group for biochemical studies, and the animals were sacrificed for histological and, immunohistochemical examinations of the myocardial tissue.
  
  
  RESULTS
  We found that the cardiac troponin T(cTn-T) levels were significantly increased in Group B when all groups were compared. In the Group C rats treated with melatonin, the cTn-T values were significantly lower than those in Groups B and D. In addition, malondialdehyde (MDA) and antioxidant enzymes including, superoxide dismutase (SOD) and myeloperoxidase (MPO) were lower than those in Group B in the melatonin treated groups. The differences were statistically significant (p < 0.05). Histopathologic and immunohistopathologic studies also supported the effectiveness of melatonin.
  
  
  CONCLUSIONS
  Our study suggests that high dose melatonin, appears to offer protection against cardiac ischemia-reperfusion injuries in rats by scavenging the free radicals and could have a potential clinical use in the management of myocardial ischemia.
authors.affiliation: Department of Cardiovascular Surgery, Erciyes University Medical Faculty, 38030 Kayseri, Turkey. ceyranh@erciyes.edu.tr
authors.forename: Hakan
authors.initials: H
authors.lastname: Ceyran
authors.forename: Figen
authors.initials: F
authors.lastname: Narin
authors.forename: Nazmi
authors.initials: N
authors.lastname: Narin
authors.forename: Hulya
authors.initials: H
authors.lastname: Akgun
authors.forename: A Bahar
authors.initials: AB
authors.lastname: Ceyran
authors.forename: Figen
authors.initials: F
authors.lastname: Ozturk
authors.forename: Yigit
authors.initials: Y
authors.lastname: Akcali
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D008550:Melatonin / Q000008:administration & dosage / Q000627:therapeutic use*; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy* / Q000473:pathology; D009195:Peroxidase / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013482:Superoxide Dismutase / Q000378:metabolism; D014336:Troponin / Q000378:metabolism
chemical_list: D000975:Antioxidants; D014336:Troponin; D008315:Malondialdehyde; D009195:Peroxidase; D013482:Superoxide Dismutase; D008550:Melatonin